192 related articles for article (PubMed ID: 17691968)
1. Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction.
Ahmadi H; Baharvand H; Ashtiani SK; Soleimani M; Sadeghian H; Ardekani JM; Mehrjerdi NZ; Kouhkan A; Namiri M; Madani-Civi M; Fattahi F; Shahverdi A; Dizaji AV
Curr Neurovasc Res; 2007 Aug; 4(3):153-60. PubMed ID: 17691968
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
[TBL] [Abstract][Full Text] [Related]
3. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
[TBL] [Abstract][Full Text] [Related]
4. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
[TBL] [Abstract][Full Text] [Related]
5. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
[TBL] [Abstract][Full Text] [Related]
6. Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone.
Ang KL; Chin D; Leyva F; Foley P; Kubal C; Chalil S; Srinivasan L; Bernhardt L; Stevens S; Shenje LT; Galiñanes M
Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):663-70. PubMed ID: 18711405
[TBL] [Abstract][Full Text] [Related]
7. Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial.
Forcillo J; Stevens LM; Mansour S; Prieto I; Salem R; Baron C; Roy DC; Larose E; Masckauchan D; Noiseux N
Can J Cardiol; 2013 Apr; 29(4):441-7. PubMed ID: 23265095
[TBL] [Abstract][Full Text] [Related]
8. Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery.
Zhao Q; Sun Y; Xia L; Chen A; Wang Z
Ann Thorac Surg; 2008 Dec; 86(6):1833-40. PubMed ID: 19021989
[TBL] [Abstract][Full Text] [Related]
9. Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction.
Soetisna TW; Sukmawan R; Setianto B; Mansyur M; Murni TW; Listiyaningsih E; Santoso A
J Card Surg; 2020 Apr; 35(4):740-746. PubMed ID: 32048356
[TBL] [Abstract][Full Text] [Related]
10. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.
Bartunek J; Vanderheyden M; Vandekerckhove B; Mansour S; De Bruyne B; De Bondt P; Van Haute I; Lootens N; Heyndrickx G; Wijns W
Circulation; 2005 Aug; 112(9 Suppl):I178-83. PubMed ID: 16159812
[TBL] [Abstract][Full Text] [Related]
11. Laser-supported CD133+ cell therapy in patients with ischemic cardiomyopathy: initial results from a prospective phase I multicenter trial.
Assmann A; Heke M; Kröpil P; Ptok L; Hafner D; Ohmann C; Martens A; Karluβ A; Emmert MY; Kutschka I; Sievers HH; Klein HM
PLoS One; 2014; 9(7):e101449. PubMed ID: 25000346
[TBL] [Abstract][Full Text] [Related]
12. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.
Mansour S; Roy DC; Bouchard V; Nguyen BK; Stevens LM; Gobeil F; Rivard A; Leclerc G; Reeves F; Noiseux N
J Cardiovasc Transl Res; 2010 Apr; 3(2):153-9. PubMed ID: 20560029
[TBL] [Abstract][Full Text] [Related]
13. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial.
Hendrikx M; Hensen K; Clijsters C; Jongen H; Koninckx R; Bijnens E; Ingels M; Jacobs A; Geukens R; Dendale P; Vijgen J; Dilling D; Steels P; Mees U; Rummens JL
Circulation; 2006 Jul; 114(1 Suppl):I101-7. PubMed ID: 16820557
[TBL] [Abstract][Full Text] [Related]
14. Encouraging experience with intracardiac transplantation of unselected autologous bone marrow cells concomitant with coronary artery bypass surgery after myocardial infarction.
Holinski S; Schmeck B; Claus B; Radtke H; Elgeti T; Holzhausen M; Konertz W
Ann Thorac Cardiovasc Surg; 2011; 17(4):383-9. PubMed ID: 21881326
[TBL] [Abstract][Full Text] [Related]
15. Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium.
Suzuki G; Iyer V; Lee TC; Canty JM
Circ Res; 2011 Oct; 109(9):1044-54. PubMed ID: 21885831
[TBL] [Abstract][Full Text] [Related]
16. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
[TBL] [Abstract][Full Text] [Related]
17. Effect of autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting on cardiac function in patients with chronic myocardial infarction.
Wang H; Wang Z; Jiang H; Ma D; Zhou W; Zhang G; Chen W; Huang J; Liu Y
Cardiology; 2015; 130(1):27-33. PubMed ID: 25501100
[TBL] [Abstract][Full Text] [Related]
18. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
[TBL] [Abstract][Full Text] [Related]
19. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
[TBL] [Abstract][Full Text] [Related]
20. Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133
Bassetti B; Carbucicchio C; Catto V; Gambini E; Rurali E; Bestetti A; Gaipa G; Belotti D; Celeste F; Parma M; Righetti S; Biava L; Arosio M; Bonomi A; Agostoni P; Scacciatella P; Achilli F; Pompilio G
Stem Cell Res Ther; 2018 Sep; 9(1):235. PubMed ID: 30217223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
